These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 34219199)
1. 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivative attenuates lupus nephritis with less effect to thymocyte development. Wei F; Zhou X; Chen H; Tian X; Liu Z; Yu B; He X; Bai C; Huang Z Immunol Res; 2021 Aug; 69(4):378-390. PubMed ID: 34219199 [TBL] [Abstract][Full Text] [Related]
2. 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as inhibitors of full-length RORγt. Lao C; Zhou X; Chen H; Wei F; Huang Z; Bai C Bioorg Chem; 2019 Sep; 90():103077. PubMed ID: 31323598 [TBL] [Abstract][Full Text] [Related]
3. 3 Zhou X; Chen H; Wei F; Zhao Q; Su Q; Liang J; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z J Immunol Res; 2019; 2019():2431617. PubMed ID: 31240232 [TBL] [Abstract][Full Text] [Related]
4. α-mangostin attenuates pristane-induced lupus nephritis by regulating Th17 differentiation. Zhou X; Chen H; Wei F; Zhao Q; Su Q; Lei Y; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z Int J Rheum Dis; 2020 Jan; 23(1):74-83. PubMed ID: 31769201 [TBL] [Abstract][Full Text] [Related]
5. A two-amino-acid substitution in the transcription factor RORγt disrupts its function in T He Z; Ma J; Wang R; Zhang J; Huang Z; Wang F; Sen S; Rothenberg EV; Sun Z Nat Immunol; 2017 Oct; 18(10):1128-1138. PubMed ID: 28846085 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo. Guendisch U; Weiss J; Ecoeur F; Riker JC; Kaupmann K; Kallen J; Hintermann S; Orain D; Dawson J; Billich A; Guntermann C PLoS One; 2017; 12(11):e0188391. PubMed ID: 29155882 [TBL] [Abstract][Full Text] [Related]
7. The Inhibitory Effects of Pentacyclic Triterpenes from Loquat Leaf against Th17 Differentiation. Zhou X; Chen H; Wei F; Zhao Q; Su Q; Lei Y; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z Immunol Invest; 2020 Aug; 49(6):632-647. PubMed ID: 31795780 [TBL] [Abstract][Full Text] [Related]
8. Sumoylation of RORγt regulates T He Z; Zhang J; Huang Z; Du Q; Li N; Zhang Q; Chen Y; Sun Z Nat Commun; 2018 Nov; 9(1):4870. PubMed ID: 30451821 [TBL] [Abstract][Full Text] [Related]
9. SRC3 Is a Cofactor for RORγt in Th17 Differentiation but Not Thymocyte Development. He Z; Zhang J; Du Q; Xu J; Gwack Y; Sun Z J Immunol; 2019 Feb; 202(3):760-769. PubMed ID: 30567733 [TBL] [Abstract][Full Text] [Related]
10. RORγt expression in T Kluger MA; Nosko A; Ramcke T; Goerke B; Meyer MC; Wegscheid C; Luig M; Tiegs G; Stahl RA; Steinmetz OM Clin Exp Immunol; 2017 Apr; 188(1):63-78. PubMed ID: 27880975 [TBL] [Abstract][Full Text] [Related]
11. T cell factor 1 regulates thymocyte survival via a RORγt-dependent pathway. Wang R; Xie H; Huang Z; Ma J; Fang X; Ding Y; Sun Z J Immunol; 2011 Dec; 187(11):5964-73. PubMed ID: 22039299 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity. Guo Y; MacIsaac KD; Chen Y; Miller RJ; Jain R; Joyce-Shaikh B; Ferguson H; Wang IM; Cristescu R; Mudgett J; Engstrom L; Piers KJ; Baltus GA; Barr K; Zhang H; Mehmet H; Hegde LG; Hu X; Carter LL; Aicher TD; Glick G; Zaller D; Hawwari A; Correll CC; Jones DC; Cua DJ Cell Rep; 2016 Dec; 17(12):3206-3218. PubMed ID: 28009290 [TBL] [Abstract][Full Text] [Related]
13. RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells. Park TY; Park SD; Cho JY; Moon JS; Kim NY; Park K; Seong RH; Lee SW; Morio T; Bothwell AL; Lee SK Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18673-8. PubMed ID: 25527718 [TBL] [Abstract][Full Text] [Related]
14. Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms. Xiao S; Yosef N; Yang J; Wang Y; Zhou L; Zhu C; Wu C; Baloglu E; Schmidt D; Ramesh R; Lobera M; Sundrud MS; Tsai PY; Xiang Z; Wang J; Xu Y; Lin X; Kretschmer K; Rahl PB; Young RA; Zhong Z; Hafler DA; Regev A; Ghosh S; Marson A; Kuchroo VK Immunity; 2014 Apr; 40(4):477-89. PubMed ID: 24745332 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo. Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202 [TBL] [Abstract][Full Text] [Related]
16. Concomitant suppression of T Na H; Lim H; Choi G; Kim BK; Kim SH; Chang YS; Nurieva R; Dong C; Chang SH; Chung Y J Allergy Clin Immunol; 2018 Jun; 141(6):2061-2073.e5. PubMed ID: 28943467 [TBL] [Abstract][Full Text] [Related]
17. IL-17C/IL-17 Receptor E Signaling in CD4 Krohn S; Nies JF; Kapffer S; Schmidt T; Riedel JH; Kaffke A; Peters A; Borchers A; Steinmetz OM; Krebs CF; Turner JE; Brix SR; Paust HJ; Stahl RAK; Panzer U J Am Soc Nephrol; 2018 Apr; 29(4):1210-1222. PubMed ID: 29483158 [TBL] [Abstract][Full Text] [Related]
18. In vivo regulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists. Skepner J; Trocha M; Ramesh R; Qu XA; Schmidt D; Baloglu E; Lobera M; Davis S; Nolan MA; Carlson TJ; Hill J; Ghosh S; Sundrud MS; Yang J Immunology; 2015 Jul; 145(3):347-56. PubMed ID: 25604624 [TBL] [Abstract][Full Text] [Related]
19. Identification of Tetraazacyclic Compounds as Novel Potent Inhibitors Antagonizing RORγt Activity and Suppressing Th17 Cell Differentiation. Ding Q; Zhao M; Yu B; Bai C; Huang Z PLoS One; 2015; 10(9):e0137711. PubMed ID: 26368822 [TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitors of RORγt: targeting Th17 cells and other applications. Huh JR; Littman DR Eur J Immunol; 2012 Sep; 42(9):2232-7. PubMed ID: 22949321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]